MedTrace Logo

EXCEL-II Stent Vesus EXCEL Stent to Treat the Patients With de Novo Coronary Artery Lesions.

NCT02057978 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 419

Last updated 2023-04-26

No results posted yet for this study

Summary

The purpose of this Randomized Study to evaluate the safety and efficacy of the Excel-II DES compared to the EXCEL DES in the treatment of patients with de novo coronary artery lesions.

Conditions

Interventions

PROCEDURE

EXCEL DES implatation

Implant DES for CAD cases

PROCEDURE

EXCEL-II DES implantation

Implant DES for CAD cases

Sponsors & Collaborators

  • JW Medical Systems Ltd

    lead INDUSTRY

Principal Investigators

  • Han Yaling, PhD · Shenyang Northern Hospital

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-08
Primary Completion
2017-10-20
Completion
2019-12-25

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02057978 on ClinicalTrials.gov